NCT07148232 Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
| NCT ID | NCT07148232 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | University of California, San Francisco |
| Condition | Tobacco Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-11-14 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 150 participants in total. It began in 2025-11-14 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older 2. Able to understand study procedures and to comply with them for the entire length of the study. 3. Ability of individual to understand a written informed consent document, and the willingness to sign it. 4. Staying at the recruitment site and meeting criteria for homelessness as defined by the Homeless Emergency and Rapid Transition to Housing Act. 5. Current smoking (smoking at least 5 cigarettes per day (cpd), verified via expired carbon monoxide (CO) \>= 8 ppm using Micro+pro Smokerlyzer). 6. Having an intention to quit smoking within the next six months. 7. English speaking. Exclusion Criteria: 1. Contraindication to any study-related procedure or assessment. 2. Reasons that preclude the use of nicotine replacement therapy (NRT) (e.g., pregnancy or myocardial infarction in the past two weeks).
Contact & Investigator
Maya Vijayaraghavan, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07148232 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tobacco Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07148232 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07148232 currently recruiting?
Yes, NCT07148232 is actively recruiting participants. Contact the research team at jessica.alway@ucsf.edu for enrollment information.
Where is the NCT07148232 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07148232 clinical trial?
NCT07148232 is sponsored by University of California, San Francisco. The principal investigator is Maya Vijayaraghavan, MD at University of California, San Francisco. The trial plans to enroll 150 participants.